Detalhe da pesquisa
1.
Quality of life from cytoreductive surgery in advanced ovarian cancer: Investigating the association between disease burden and surgical complexity in the international, prospective, SOCQER-2 cohort study.
BJOG
; 129(7): 1122-1132, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34865316
2.
Metronomic oral cyclophosphamide in relapsed ovarian cancer.
Int J Gynecol Cancer
; 31(7): 1037-1044, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34016703
3.
Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer.
Br J Cancer
; 114(7): 723-30, 2016 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27002934
4.
European Network of Gynaecological Oncological Trial Groups' Requirements for Trials Between Academic Groups and Industry Partners--First Update 2015.
Int J Gynecol Cancer
; 25(7): 1328-30, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26067859
5.
Phase II activity of belinostat (PXD-101), carboplatin, and paclitaxel in women with previously treated ovarian cancer.
Int J Gynecol Cancer
; 22(6): 979-86, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22694911
6.
Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer.
Br J Cancer
; 114(12): e21, 2016 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27228289
7.
Clinical trials in recurrent ovarian cancer.
Int J Gynecol Cancer
; 21(4): 771-5, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21543939
8.
The European Network for Gynaecological Oncological Trial Groups Charta for Privileged Partnership.
Int J Gynecol Cancer
; 25(6): 1094-5, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26098090
9.
Managing vulvovaginal atrophy after breast cancer.
Post Reprod Health
; 24(4): 163-165, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30348046